Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 296

1.

Effects of eradication of HCV on cardiovascular risk and preclinical atherosclerosis in HIV/HCV-coinfected patients.

Carrero A, Berenguer J, Hontañón V, Navarro J, Hernández-Quero J, Galindo MJ, Quereda C, Santos I, Téllez MJ, Ortega E, Sanz J, Medrano LM, Pérez-Latorre L, Bellón JM, Resino S, Bermejo J, González-García J; GeSIDA 3603b Study Group.

J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002260. [Epub ahead of print]

PMID:
31913996
2.

Pneumococcal vaccination in adult people living with HIV on suppressive antiretroviral therapy: a case-control study.

Vivancos-Gallego MJ, Muriel A, Serrano-Villar S, Moreno-Zamora A, Pérez-Elías MJ, Quereda C, Casado JL, Sánchez-Conde M, Del Campo S, Dronda F, Sánchez-Díaz AM, Valencia-Martín JL, Moreno S.

Int J STD AIDS. 2019 Dec 22:956462419882128. doi: 10.1177/0956462419882128. [Epub ahead of print] No abstract available.

PMID:
31865862
3.

Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study.

Garcia-Broncano P, Medrano LM, Berenguer J, Brochado-Kith O, González-García J, Jiménez-Sousa MÁ, Quereda C, Sanz J, Téllez MJ, Díaz L, JIménez JL, Resino S; GESIDA 3603b Study Group.

J Infect. 2020 Jan;80(1):99-110. doi: 10.1016/j.jinf.2019.09.020. Epub 2019 Oct 1.

PMID:
31585189
4.

Impact of a structured HIV testing program in a hospital emergency department and a primary care center.

Gómez-Ayerbe C, Martínez-Sanz J, Muriel A, Pérez Elías P, Moreno A, Barea R, Polo L, Cano A, Uranga A, Santos C, Casado JL, Quereda C, Robledillo G, Díaz-de Santiago A, Vivancos MJ, Dronda F, Navas E, Moreno S, Pérez Elías MJ.

PLoS One. 2019 Aug 1;14(8):e0220375. doi: 10.1371/journal.pone.0220375. eCollection 2019.

5.

Hypermucoviscous Klebsiella pneumoniae: A challenge in community acquired infection.

Sánchez-López J, García-Caballero A, Navarro-San Francisco C, Quereda C, Ruiz-Garbajosa P, Navas E, Dronda F, Morosini MI, Cantón R, Diez-Aguilar M.

IDCases. 2019 May 3;17:e00547. doi: 10.1016/j.idcr.2019.e00547. eCollection 2019.

6.

Correction: Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.

Ventero MP, Fuentes-Baile M, Quereda C, Perez-Valeciano E, Alenda C, Garcia-Morales P, Esposito D, Dorado P, Barbera VM, Sacedan M.

PLoS One. 2019 Apr 16;14(4):e0215714. doi: 10.1371/journal.pone.0215714. eCollection 2019.

7.

Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.

Ventero MP, Fuentes-Baile M, Quereda C, Perez-Valeciano E, Alenda C, Garcia-Morales P, Esposito D, Dorado P, Manuel Barbera V, Saceda M.

PLoS One. 2019 Feb 27;14(2):e0212581. doi: 10.1371/journal.pone.0212581. eCollection 2019. Erratum in: PLoS One. 2019 Apr 16;14(4):e0215714.

8.

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).

Vázquez-Morón S, Berenguer J, González-García J, Jiménez-Sousa MÁ, Canorea I, Guardiola JM, Crespo M, Quereda C, Sanz J, Carrero A, Hontañón V, Avellón A, Resino S.

Sci Rep. 2019 Feb 4;9(1):1143. doi: 10.1038/s41598-018-37328-6.

9.

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status.

Garcia-Broncano P, Medrano LM, Berenguer J, González-García J, Jiménez-Sousa MÁ, Carrero A, Hontañón V, Guardiola JM, Crespo M, Quereda C, Sanz J, García-Gómez AB, Jimenez JL, Resino S; GESIDA 3603b Study Group.

Cells. 2018 Nov 2;7(11). pii: E196. doi: 10.3390/cells7110196.

10.

Impairment of photoreceptor ribbon synapses in a novel Pomt1 conditional knockout mouse model of dystroglycanopathy.

Rubio-Fernández M, Uribe ML, Vicente-Tejedor J, Germain F, Susín-Lara C, Quereda C, Montoliu L, de la Villa P, Martín-Nieto J, Cruces J.

Sci Rep. 2018 Jun 4;8(1):8543. doi: 10.1038/s41598-018-26855-x.

11.

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.

Medrano LM, Garcia-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontañón V, Muñoz-Fernández MÁ, Resino S; GESIDA 3603b Study Group.

AIDS. 2018 Jun 1;32(9):1095-1105. doi: 10.1097/QAD.0000000000001787.

PMID:
29438197
12.

Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes.

Haro C, Uribe ML, Quereda C, Cruces J, Martín-Nieto J.

Mol Vis. 2018 Jan 20;24:43-58. eCollection 2018.

13.

Treatment of hepatitisC virus with direct-acting antivirals: Practical aspects and current situation.

Vivancos MJ, Moreno A, Quereda C.

Rev Clin Esp. 2018 Jan - Feb;218(1):29-37. doi: 10.1016/j.rce.2017.07.006. Epub 2017 Sep 22. English, Spanish.

PMID:
28947060
14.

Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.

Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J; GESIDA HIV/HCV Cohort Study Group.

Hepatology. 2017 Aug;66(2):344-356. doi: 10.1002/hep.29071. Epub 2017 Jun 22.

15.

Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis.

Fernandez-Juarez G, Villacorta J, Ruiz-Roso G, Panizo N, Martinez-Marín I, Marco H, Arrizabalaga P, Díaz M, Perez-Gómez V, Vaca M, Rodríguez E, Cobelo C, Fernandez L, Avila A, Praga M, Quereda C, Ortiz A.

Clin Kidney J. 2016 Jun;9(3):381-6. doi: 10.1093/ckj/sfw028. Epub 2016 May 24.

16.

Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.

Sainz-de-la-Maza S, Casado JL, Pérez-Elías MJ, Moreno A, Quereda C, Moreno S, Corral I.

Eur J Neurol. 2016 May;23(5):919-25. doi: 10.1111/ene.12963. Epub 2016 Feb 23.

PMID:
26914970
17.

Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening.

Elías MJ, Gómez-Ayerbe C, Elías PP, Muriel A, de Santiago AD, Martinez-Colubi M, Moreno A, Santos C, Polo L, Barea R, Robledillo G, Uranga A, Espín AC, Quereda C, Dronda F, Casado JL, Moreno S.

Medicine (Baltimore). 2016 Feb;95(5):e2612. doi: 10.1097/MD.0000000000002612.

18.

Bone fractures and lumbar mineral density after renal transplantation. A long-term cross-sectional study.

Jiménez S, Marcén R, Vaamonde C, Caballero C, Fernández-Rodríguez A, Villafruela JJ, Galeano C, Teruel JL, Quereda C.

Clin Transplant. 2016 Feb;30(2):131-7. doi: 10.1111/ctr.12666.

PMID:
26546290
19.

Teaching innovations in ultrasound-guided renal biopsy.

Rivera Gorrín M, Correa Gorospe C, Burguera V, Ortiz Chercoles AI, Liaño F, Quereda C.

Nefrologia. 2016;36(1):1-4. doi: 10.1016/j.nefro.2015.07.011. Epub 2015 Oct 31. English, Spanish. No abstract available.

20.

Palliative peritoneal dialysis: Implementation of a home care programme for terminal patients treated with peritoneal dialysis (PD).

Gorrin MR, Teruel-Briones JL, Vion VB, Rexach L, Quereda C.

Nefrologia. 2015;35(2):146-9. doi: 10.1016/j.nefro.2015.05.015. Epub 2015 Jun 23. English, Spanish.

21.

Choosing conservative therapy in chronic kidney disease.

Teruel JL, Burguera Vion V, Gomis Couto A, Rivera Gorrín M, Fernández-Lucas M, Rodríguez Mendiola N, Quereda C.

Nefrologia. 2015;35(3):273-9. doi: 10.1016/j.nefro.2015.05.005. Epub 2015 Jun 18. English, Spanish.

22.

Progressive multifocal leukoencephalopathy mimicking milliary CNS tuberculosis.

Corral I, Quereda C, Dronda F, Navas E, Hermida JM, Moreno C, Martínez-San-Millán J.

J Neurovirol. 2015 Dec;21(6):691-3. doi: 10.1007/s13365-015-0367-6. Epub 2015 Aug 5. No abstract available.

PMID:
26242918
23.

Brief Report: Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1-HCV-Coinfected Patients Who Either Received Interferon-α/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance.

Abad-Fernández M, Dronda F, Moreno A, Casado JL, Pérez-Elías MJ, Quereda C, Moreno S, Vallejo A.

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):286-90. doi: 10.1097/QAI.0000000000000608.

PMID:
26181704
24.

Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.

Casado JL, Mena A, Bañón S, Castro A, Quereda C, Moreno A, Pedreira J, Moreno S.

HIV Med. 2016 Jan;17(1):62-7. doi: 10.1111/hiv.12274. Epub 2015 Jun 30.

25.

Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.

Casado JL, Esteban MA, Bañón S, Moreno A, Perez-Elías MJ, Mateos ML, Moreno S, Quereda C.

Dig Dis Sci. 2015 Nov;60(11):3473-81. doi: 10.1007/s10620-015-3773-y. Epub 2015 Jun 26.

PMID:
26112991
26.

Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients.

Aldámiz-Echevarría T, González-García J, Von Wichmann MA, Crespo M, López-Aldeguer J, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Bellón JM, Montes M, Berenguer J.

Ann Hepatol. 2015 Jul-Aug;14(4):464-9.

27.

Hydrothorax secondary to a malpositioned peritoneal dialysis catheter.

Gorrín MR, Rodríguez-Mendiola N, Saico SP, de Nicolás VD, Rioja ME, Quereda C.

Perit Dial Int. 2015 May-Jun;35(3):365-6. doi: 10.3747/pdi.2014.00133. No abstract available.

28.

Black esophagus in the early kidney post-transplant period.

Caravaca-Fontán F, Jimenez S, Fernández-Rodríguez A, Marcén R, Quereda C.

Clin Kidney J. 2014 Dec;7(6):613-4. doi: 10.1093/ckj/sfu094. Epub 2014 Sep 14. No abstract available.

29.

Effects of a single, high oral dose of 25-hydroxycholecalciferol on the mineral metabolism markers in hemodialysis patients.

Merino JL, Teruel JL, Fernández-Lucas M, Villafruela JJ, Bueno B, Gomis A, Paraíso V, Quereda C.

Ther Apher Dial. 2015 Jun;19(3):212-9. doi: 10.1111/1744-9987.12279. Epub 2015 Feb 6.

PMID:
25656524
30.

Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.

Abad-Fernández M, Moreno A, Dronda F, del Campo S, Quereda C, Casado JL, Pérez-Elías MJ, Moreno S, Vallejo A.

AIDS. 2015 Feb 20;29(4):401-9. doi: 10.1097/QAD.0000000000000555.

PMID:
25565497
31.

Consensus document on the management of renal disease in HIV-infected patients.

AIDS Working Group (GESIDA) of the Spanish Society of InfectiousDiseases and Clinical Microbiology (SEIMC); Spanish Society of Nephrology (S.E.N.); Spanish Society of Clinical Chemistry and Molecular Pathology (SEQC), Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofan F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, Gracia S, Iribarren JA, Knobel H, López-Aldeguer J, Lozano F, Martínez-Castelao A, Martínez E, Mazuecos MA, Miralles C, Montañés R, Negredo E, Palacios R, Pérez-Elías MJ, Portilla J, Praga M, Quereda C, Rivero A, Santamaría JM, Sanz J, Sanz J, Miró JM.

Nefrologia. 2014;34 Suppl 2:1-81. doi: 10.3265/Nefrologia.pre2014.Jul.12674. English, Spanish.

32.

Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.

Berenguer J, Zamora FX, Aldámiz-Echevarría T, Von Wichmann MA, Crespo M, López-Aldeguer J, Carrero A, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Barros C, Ortega E, Pulido F, Rubio R, Mallolas J, Tural C, Jusdado JJ, Pérez G, Díez C, Álvarez-Pellicer J, Esteban H, Bellón JM, González-García J; Grupo de Estudio del SIDA (GESIDA) HIV/HCV Cohort Study Group.

Clin Infect Dis. 2015 Mar 15;60(6):950-8. doi: 10.1093/cid/ciu939. Epub 2014 Nov 24.

PMID:
25422386
33.

Executive summary of the consensus document on the management of renal disease in HIV-infected patients.

Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofan F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, Gracia S, Iribarren JA, Knobel H, Lopez-Aldeguer J, Lozano F, Martínez-Castelao A, Martinez E, Mazuecos MA, Miralles C, Montañes R, Negredo E, Palacios R, Pérez-Elías MJ, Portilla J, Praga M, Quereda C, Rivero A, Santamaria JM, Sanz J, Sanz J, Miró JM.

Nefrologia. 2014 Nov 17;34(6):768-88. doi: 10.3265/Nefrologia.pre2014.Sep.12745. English, Spanish.

34.

A clinical and pharmacokinetic study of the combination of etravirine plus raltegravir in HIV patients with expanded intolerance or resistance.

Bañón S, Moreno A, Quereda C, Gomez C, de Santiago AD, Perez-Elías MJ, Moreno S, Casado JL.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19804. doi: 10.7448/IAS.17.4.19804. eCollection 2014.

35.

Comparison of routine versus targeted HIV testing strategies: coverage and estimated missed infections in emergency room and primary care centre.

Elías MJ, Gomez-Ayerbe C, Muriel A, Calonge ME, Diaz A, Elías PP, Martinez-Colubi M, Uranga A, Santos C, Moreno A, Quereda C, Navas E, Moreno S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19671. doi: 10.7448/IAS.17.4.19671. eCollection 2014.

36.

[Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients].

Panel de Expertos del Grupo de Estudio de Sida (GESIDA); la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC); la Sociedad Española de Nefrología (SEN); la Sociedad Española de Bioquímica Clínica y Patología Molecular (SEQC), Gorriz JL, Gutiérrez F, Trullàs JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofán F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, Gràcia S, Iribarren JA, Knobel H, López-Aldeguer J, Lozano F, Martínez-Castelao A, Martínez E, Mazuecos MA, Miralles C, Montañés R, Negredo E, Palacios R, Pérez-Elías MJ, Portilla J, Praga M, Quereda C, Rivero A, Santamaría JM, Sanz J, Sanz J, Miró JM.

Enferm Infecc Microbiol Clin. 2014 Nov;32(9):583-97. doi: 10.1016/j.eimc.2014.09.002. Epub 2014 Oct 7. Spanish.

37.

Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir.

Ramirez ML, Vargas FX, González-Garcia J, Quereda C, Pérez-Elías MJ, de Cea AM, Barros C, Condés E, Moreno JS, Santos I, Torralba M, Aldamiz-Echevarria T, Moreno A.

AIDS. 2014 Oct 23;28(16):2487-9. doi: 10.1097/QAD.0000000000000425. No abstract available.

PMID:
25265233
38.

Home care programme for patients with advanced chronic kidney disease. A two-year experience.

Teruel JL, Rexach L, Burguera V, Gomis A, Rodríguez-Mendiola N, Díaz A, Collazo S, Quereda C.

Nefrologia. 2014;34(5):611-6. doi: 10.3265/Nefrologia.pre2014.Jun.12595. English, Spanish.

39.

Central nervous system involvement in adult patients with invasive infection caused by Streptococcus agalactiae.

Oyanguren B, Esteban L, Guillán M, de Felipe A, Alonso Cánovas A, Navas E, Quereda C, Corral I.

Neurologia. 2015 Apr;30(3):158-62. doi: 10.1016/j.nrl.2013.12.002. Epub 2014 Sep 10. English, Spanish.

40.

Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis.

Berenguer J, Zamora FX, Carrero A, Von Wichmann MA, Crespo M, López-Aldeguer J, Aldámiz-Echevarría T, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Esteban H, Bellón JM, González-García J; GESIDA HIVHCV Cohort Study Group.

J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):280-7. doi: 10.1097/QAI.0000000000000156.

PMID:
25157646
41.

Subphrenic abscess as a complication of hemodialysis catheter-related infection.

Caravaca F, Burguera V, Fernández-Lucas M, Teruel JL, Quereda C.

Case Rep Nephrol. 2014;2014:502019. doi: 10.1155/2014/502019. Epub 2014 Jul 10.

42.

Staphylococcus lentus peritonitis: a case report.

Rivera M, Dominguez MD, Mendiola NR, Roso GR, Quereda C.

Perit Dial Int. 2014 Jun;34(4):469-70. doi: 10.3747/pdi.2012.00303. No abstract available.

43.

Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.

Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, Oliveras A, Portolés J, Rubio E, Segura J, Aranda P, de Francisco AL, Del Pino MD, Fernández-Vega F, Górriz JL, Luño J, Marín R, Martínez I, Martínez-Castelao A, Orte LM, Quereda C, Rodríguez-Pérez JC, Rodríguez M, Ruilope LM.

Nefrologia. 2014 May 21;34(3):302-16. doi: 10.3265/Nefrologia.pre2014.Feb.12464. Epub 2014 Mar 6. English, Spanish.

44.

Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.

Serrano-Villar S, Pérez-Elías MJ, Dronda F, Casado JL, Moreno A, Royuela A, Pérez-Molina JA, Sainz T, Navas E, Hermida JM, Quereda C, Moreno S.

PLoS One. 2014 Jan 30;9(1):e85798. doi: 10.1371/journal.pone.0085798. eCollection 2014.

45.

Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study.

Montes Ramírez ML, Miró JM, Quereda C, Jou A, von Wichmann MÁ, Berenguer J, González-García JJ, Hernando A, Ortega E, Sanz J, Arribas JR; GESIDA 3703.FIPSE 36466503-N5 NEAT Study Group.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):82-6. doi: 10.1097/QAI.0b013e3182a685dc.

PMID:
24419065
46.

Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection.

Casado JL, Quereda C, Moreno A, Pérez-Elías MJ, Martí-Belda P, Moreno S.

J Viral Hepat. 2013 Dec;20(12):829-37. doi: 10.1111/jvh.12108. Epub 2013 Apr 25.

PMID:
24304452
47.

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C).

Hernández-Novoa B, Moreno A, Pérez-Elías MJ, Quereda C, Dronda F, Casado JL, Madrid-Elena N, Aguilar M, Fumero E, Moltó J, Moreno S.

J Antimicrob Chemother. 2014 Feb;69(2):471-5. doi: 10.1093/jac/dkt386. Epub 2013 Oct 4.

PMID:
24097843
48.

Melioidosis in traveler from Africa to Spain.

Morosini MI, Quereda C, Gil H, Anda P, Núñez-Murga M, Cantón R, López-Vélez R.

Emerg Infect Dis. 2013 Oct;19(10):1656-9. doi: 10.3201/eid1910.121785.

49.

Treatment with megestrol acetate increases muscle mass in uraemic patients.

Fernández-Lucas M, Elías S, Ruiz-Roso G, Díaz M, Teruel-Briones JL, Quereda C.

Nefrologia. 2013;33(3):425-6. doi: 10.3265/Nefrologia.pre2013.Feb.11819. English, Spanish. No abstract available.

50.

Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections.

Serrano-Villar S, Quereda C, Moreno A, Pérez-Elías MJ, Casado JL, Royuela A, Dronda F, Navas E, Hermida JM, Moreno S.

Clin Infect Dis. 2013 Aug;57(3):458-64. doi: 10.1093/cid/cit221. Epub 2013 Apr 10.

PMID:
23575196

Supplemental Content

Loading ...
Support Center